A COST-EFFECTIVENESS STUDY OF INTRAVENOUS IMMUNOGLOBULIN IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIA PURPURA PATIENTS WITH LIFE-THREATENING BLEEDING

被引：0

作者：

Sruamsiri, R. ^{[1
]}

Dilokthornsakul, P. ^{[1
]}

Chaiyakunapruk, N. ^{[2
]}

Pratoomsoot, C.

机构：

[1] Naresuan Univ, Ctr Pharmaceut Outcomes Res, Muang, Phitsanulok, Thailand

[2] Discipline Pharm, Selangor, Malaysia

来源：

VALUE IN HEALTH | 2014年 / 17卷 / 03期

关键词：

D O I：

10.1016/j.jval.2014.03.1332

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSY27

引用

页码：A228 / A228

页数：1

共 50 条

[31] Economic impact and conservation of intravenous immunoglobulin (IVIG) through therapeutic substitution with anti-D in patients with idiopathic thrombocytopenia purpura (ITP) at an urban teaching hospital in Staten Island, NY
Coyne, M.
[J]. VALUE IN HEALTH, 2008, 11 (03) : A159 - A160
[32] The cost-effectiveness of intravenous proton pump inhibitor continuous infusion (IV PPI) administered before endoscopy in the treatment of patients with nonvariceal upper GI bleeding
Barkun, A
Kennedy, W
Herba, K
Fallone, CA
[J]. GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB85 - AB85
[33] Intravenous immunoglobulin (IVIG) a life saving therapy for hemorrhage control in patients with idiopathic thrombocytopenic purpura (ITP) before surgery, labor & delivery which otherwise is not responding to other measures
Ri-Sultan
Muhammad-Ishaq
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S194 - S194
[34] COST-EFFECTIVENESS STUDY OF THE USE OF FIBRINOGEN CONCENTRATE (CLOTTAFACT®) IN PATIENTS WITH MAJOR BLEEDING AND TRAUMA REQUIRING SURGERY IN MEXICAN PUBLIC HEALTH INSTITUTIONS
Gay Molina, J.
Valls, M.
Morales, E.
Grimaldi, A.
Delgado, J.
[J]. VALUE IN HEALTH, 2024, 27 (06) : S142 - S143
[35] A PROSPECTIVE STUDY ON COPING STRATEGIES AND QUALITY OF LIFE IN PATIENTS AFTER STROKE, ASSESSING PROGNOSTIC RELATIONSHIPS AND ESTIMATES OF COST-EFFECTIVENESS
Darlington, Anne-Sophie E.
Dippel, Diederik W. J.
Ribbers, Gerard M.
van Balen, Romke
Passchier, Jan
Busschbach, Jan J. V.
[J]. JOURNAL OF REHABILITATION MEDICINE, 2009, 41 (04) : 237 - 241
[36] The cost-effectiveness of high dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy
Barkun, A
Adam, V
Kennedy, WA
Fallone, CA
Herba, K
Bardou, K
[J]. VALUE IN HEALTH, 2003, 6 (03) : 248 - 248
[37] The cost-effectiveness of continuous infusion intravenous proton pump inhibitors (IV PPI) administered prior to endoscopy in the treatment of patients presenting with suspected upper GI bleeding (UGIB)
Alsabah, Salman
Barkun, Alan N.
Herba, Karl
Adam, Viviane
Kennedy, Wendy
layrargues, Gilles Pomier
[J]. GASTROENTEROLOGY, 2007, 132 (04) : A164 - A164
[38] High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis
Barkun, AN
Herba, K
Adam, V
Kennedy, W
Fallone, CA
Bardou, M
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (05) : 591 - 600
[39] The cost-effectiveness of intravenous proton pump inhibitor continuous infusion (IV PPI) administered prior to endoscopy in the treatment of patients with non-variceal upper GI bleeding.
Barkun, A
Kennedy, W
Herba, K
Fallone, CA
[J]. GASTROENTEROLOGY, 2002, 122 (04) : A682 - A682
[40] The cost-effectiveness of high-dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy
Barkun, AN
Adam, V
Kennedy, N
Fallone, CA
Herba, K
Bardou, M
[J]. GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB149 - AB149

← 1 2 3 4 5 →